Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Real-world validation of the 2017 McDonald criteria for pediatric MS.

Wong YYM, de Mol CL, van der Vuurst de Vries RM, van Pelt ED, Ketelslegers IA, Catsman-Berrevoets CE, Neuteboom RF, Hintzen RQ.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 14;6(2):e528. doi: 10.1212/NXI.0000000000000528. eCollection 2019 Mar.

2.

Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study.

van der Louw EJTM, Reddingius RE, Olieman JF, Neuteboom RF, Catsman-Berrevoets CE.

Pediatr Blood Cancer. 2019 Mar;66(3):e27561. doi: 10.1002/pbc.27561. Epub 2018 Nov 28.

PMID:
30484948
3.

Correction to: Relevance of neuroimaging for neurocognitive and behavioral outcome after pediatric traumatic brain injury.

Königs M, Pouwels PJ, Ernest van Heurn LW, Bakx R, Jeroen Vermeulen R, Goslings JC, Poll-The BT, van der Wees M, Catsman-Berrevoets CE, Oosterlaan J.

Brain Imaging Behav. 2018 Jul 20. doi: 10.1007/s11682-018-9930-0. [Epub ahead of print]

PMID:
30027394
4.

T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.

Wong YYM, van der Vuurst de Vries RM, van Pelt ED, Ketelslegers IA, Melief MJ, Wierenga AF, Catsman-Berrevoets CE, Neuteboom RF, Hintzen RQ.

Mult Scler. 2018 Nov;24(13):1715-1724. doi: 10.1177/1352458518786655. Epub 2018 Jul 18.

5.

The Brains Ahead! intervention for children and adolescents with mild traumatic brain injury and their caregivers: rationale and description of the treatment protocol.

Renaud MI, van de Port IG, Catsman-Berrevoets CE, Bovens N, Lambregts SA, van Heugten CM.

Clin Rehabil. 2018 Nov;32(11):1440-1448. doi: 10.1177/0269215518785418. Epub 2018 Jul 9.

PMID:
29984603
6.

Early Seizure Freedom Is a Prognostic Factor for Survival in Patients with West Syndrome.

Krijgh EJC, Catsman-Berrevoets CE, Neuteboom RF.

Neuropediatrics. 2018 Aug;49(4):279-282. doi: 10.1055/s-0038-1654708. Epub 2018 May 21.

PMID:
29783274
7.

Evaluation of management and guideline adherence in children with mild traumatic brain injury.

Broers MC, Niermeijer JF, Kotsopoulos IAW, Lingsma HF, Bruinenberg JFM, Catsman-Berrevoets CE.

Brain Inj. 2018;32(8):1028-1039. doi: 10.1080/02699052.2018.1469047. Epub 2018 May 18.

PMID:
29775090
8.

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis.

de Bruijn MAAM, Aarsen FK, van Oosterhout MP, van der Knoop MM, Catsman-Berrevoets CE, Schreurs MWJ, Bastiaansen DEM, Sillevis Smitt PAE, Neuteboom RF, Titulaer MJ; CHANCE Study Group.

Neurology. 2018 May 29;90(22):e1997-e2005. doi: 10.1212/WNL.0000000000005605. Epub 2018 Apr 27.

9.

Neurological outcome in children and youth with acquired brain injury 2-year post-injury.

Lambregts SAM, Van Markus-Doornbosch F, Catsman-Berrevoets CE, Berger MAM, De Kloet AJ, Hilberink SR, Roebroeck ME.

Dev Neurorehabil. 2018 Oct;21(7):465-474. doi: 10.1080/17518423.2018.1460770. Epub 2018 Apr 13.

PMID:
29652209
10.

Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

de Mol CL, Wong YYM, van Pelt ED, Ketelslegers IA, Bakker DP, Boon M, Braun KPJ, van Dijk KGJ, Eikelenboom MJ, Engelen M, Geleijns K, Haaxma CA, Niermeijer JMF, Niks EH, Peeters EAJ, Peeters-Scholte CMPCD, Poll-The BT, Portier RP, de Rijk-van Andel JF, Samijn JPA, Schippers HM, Snoeck IN, Stroink H, Vermeulen RJ, Verrips A, Visscher F, Vles JSH, Willemsen MAAP, Catsman-Berrevoets CE, Hintzen RQ, Neuteboom RF.

J Neurol. 2018 Jun;265(6):1310-1319. doi: 10.1007/s00415-018-8835-6. Epub 2018 Mar 22.

11.

Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.

Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, van Pelt ED, Catsman-Berrevoets CE, Hintzen RQ, Deiva K, Lim MJ, Rostásy K, Neuteboom RF.

Eur J Neurol. 2018 May;25(5):782-786. doi: 10.1111/ene.13602. Epub 2018 Mar 9.

PMID:
29443442
12.

Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).

Eijk S, Mous SE, Dieleman GC, Dierckx B, Rietman AB, de Nijs PFA, Ten Hoopen LW, van Minkelen R, Elgersma Y, Catsman-Berrevoets CE, Oostenbrink R, Legerstee JS.

J Autism Dev Disord. 2018 Jul;48(7):2278-2285. doi: 10.1007/s10803-018-3478-0.

13.

Cognitive function and participation in children and youth with mild traumatic brain injury two years after injury.

Lambregts SAM, Smetsers JEM, Verhoeven IMAJ, de Kloet AJ, van de Port IGL, Ribbers GM, Catsman-Berrevoets CE.

Brain Inj. 2018;32(2):230-241. doi: 10.1080/02699052.2017.1406990. Epub 2017 Nov 30.

PMID:
29190153
14.

Development of emotional and behavioral problems in neurofibromatosis type 1 during young childhood.

Rietman AB, Oostenbrink R, van Noort K, Franken MJP, Catsman-Berrevoets CE, Aarsen FK, Hendriksen JG, de Nijs PFA.

Am J Med Genet A. 2017 Sep;173(9):2373-2380. doi: 10.1002/ajmg.a.38323. Epub 2017 Jun 19.

PMID:
28627810
15.

Risk factors for development of postoperative cerebellar mutism syndrome in children after medulloblastoma surgery.

Pols SYCV, van Veelen MLC, Aarsen FK, Gonzalez Candel A, Catsman-Berrevoets CE.

J Neurosurg Pediatr. 2017 Jul;20(1):35-41. doi: 10.3171/2017.2.PEDS16605. Epub 2017 May 12.

PMID:
28498095
16.

Validated age-specific reference values for CSF total protein levels in children.

Kahlmann V, Roodbol J, van Leeuwen N, Ramakers CRB, van Pelt D, Neuteboom RF, Catsman-Berrevoets CE, de Wit MCY, Jacobs BC.

Eur J Paediatr Neurol. 2017 Jul;21(4):654-660. doi: 10.1016/j.ejpn.2017.03.006. Epub 2017 Apr 8.

PMID:
28461111
17.

Fatigue and physical functioning in children with multiple sclerosis and acute disseminated encephalomyelitis.

Toussaint-Duyster LC, Wong YYM, Van der Cammen-van Zijp MH, Van Pelt-Gravesteijn D, Catsman-Berrevoets CE, Hintzen RQ, Neuteboom RF.

Mult Scler. 2018 Jun;24(7):982-990. doi: 10.1177/1352458517706038. Epub 2017 Apr 26.

18.

Motor nerve excitability after childhood Guillain-Barré syndrome.

Drenthen J, Roodbol J, Maathuis EM, Catsman-Berrevoets CE, Blok JH, de Wit MY, Jacobs BC.

J Peripher Nerv Syst. 2017 Jun;22(2):100-105. doi: 10.1111/jns.12213.

PMID:
28432749
19.

The structural connectome of children with traumatic brain injury.

Königs M, van Heurn LWE, Bakx R, Vermeulen RJ, Goslings JC, Poll-The BT, van der Wees M, Catsman-Berrevoets CE, Oosterlaan J, Pouwels PJW.

Hum Brain Mapp. 2017 Apr 21. doi: 10.1002/hbm.23614. [Epub ahead of print]

PMID:
28429381
20.

Very long-term sequelae of craniopharyngioma.

Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM.

Eur J Endocrinol. 2017 Jun;176(6):755-767. doi: 10.1530/EJE-17-0044. Epub 2017 Mar 21.

PMID:
28325825
21.

Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.

Roodbol J, de Wit MY, van den Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, Jacobs BC.

J Neurol. 2017 May;264(5):856-861. doi: 10.1007/s00415-017-8429-8. Epub 2017 Mar 1.

22.

Cerebellar mutism syndrome: cause and rehabilitation.

Catsman-Berrevoets CE.

Curr Opin Neurol. 2017 Apr;30(2):133-139. doi: 10.1097/WCO.0000000000000426. Review.

PMID:
28118304
23.

Ketogenic diet therapy for epilepsy during pregnancy: A case series.

van der Louw EJ, Williams TJ, Henry-Barron BJ, Olieman JF, Duvekot JJ, Vermeulen MJ, Bannink N, Williams M, Neuteboom RF, Kossoff EH, Catsman-Berrevoets CE, Cervenka MC.

Seizure. 2017 Feb;45:198-201. doi: 10.1016/j.seizure.2016.12.019. Epub 2016 Dec 26.

24.

Relevance of neuroimaging for neurocognitive and behavioral outcome after pediatric traumatic brain injury.

Königs M, Pouwels PJ, Ernest van Heurn LW, Bakx R, Jeroen Vermeulen R, Carel Goslings J, Poll-The BT, van der Wees M, Catsman-Berrevoets CE, Oosterlaan J.

Brain Imaging Behav. 2018 Feb;12(1):29-43. doi: 10.1007/s11682-017-9673-3. Erratum in: Brain Imaging Behav. 2018 Jul 20;:.

25.

Pediatric traumatic brain injury affects multisensory integration.

Königs M, Weeda WD, van Heurn LW, Vermeulen RJ, Goslings JC, Luitse JS, Poll-The BT, Beelen A, van der Wees M, Kemps RJ, Catsman-Berrevoets CE, Oosterlaan J.

Neuropsychology. 2017 Feb;31(2):137-148. doi: 10.1037/neu0000302. Epub 2016 Sep 29.

PMID:
27683950
26.

Evolution of MRI abnormalities in paediatric acute disseminated encephalomyelitis.

Wong YYM, van Pelt ED, Ketelslegers IA, Catsman-Berrevoets CE, Hintzen RQ, Neuteboom RF; Dutch Study Group for Paediatric Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Eur J Paediatr Neurol. 2017 Mar;21(2):300-304. doi: 10.1016/j.ejpn.2016.08.014. Epub 2016 Sep 6.

PMID:
27670632
27.

Health-related quality of life and emotional problems in children surviving brain tumor treatment: A descriptive study of 2 cohorts.

Dessens AB, van Herwerden MC, Aarsen FK, Birnie E, Catsman-Berrevoets CE.

Pediatr Hematol Oncol. 2016 Aug;33(5):282-294. Epub 2016 Jun 23.

PMID:
27337046
28.
29.

Feedback learning and behavior problems after pediatric traumatic brain injury.

Königs M, van Heurn LW, Vermeulen RJ, Goslings JC, Luitse JS, Poll-Thé BT, Beelen A, van der Wees M, Kemps RJ, Catsman-Berrevoets CE, Luman M, Oosterlaan J.

Psychol Med. 2016 May;46(7):1473-84. doi: 10.1017/S0033291716000106. Epub 2016 Mar 8.

PMID:
26951460
30.

Impaired Visual Integration in Children with Traumatic Brain Injury: An Observational Study.

Königs M, Weeda WD, van Heurn LW, Vermeulen RJ, Goslings JC, Luitse JS, Poll-Thé BT, Beelen A, van der Wees M, Kemps RJ, Catsman-Berrevoets CE, Oosterlaan J.

PLoS One. 2015 Dec 4;10(12):e0144395. doi: 10.1371/journal.pone.0144395. eCollection 2015.

31.

Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.

Scheepe JR, Wong YY, van Pelt ED, Ketelslegers IA, Catsman-Berrevoets CE, van den Hoek J, Hintzen RQ, Neuteboom RF.

Mult Scler. 2016 Oct;22(11):1490-1494. Epub 2015 Nov 20.

PMID:
26589894
32.

Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy.

van der Louw EJ, Desadien R, Vehmeijer FO, van der Sijs H, Catsman-Berrevoets CE, Neuteboom RF.

Seizure. 2015 Nov;32:75-7. doi: 10.1016/j.seizure.2015.09.007. Epub 2015 Sep 21.

33.

Gray matter-related proteins are associated with childhood-onset multiple sclerosis.

Singh V, van Pelt ED, Stoop MP, Stingl C, Ketelslegers IA, Neuteboom RF, Catsman-Berrevoets CE, Luider TM, Hintzen RQ.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e155. doi: 10.1212/NXI.0000000000000155. eCollection 2015 Oct.

34.

Pediatric Traumatic Brain Injury and Attention Deficit.

Königs M, Heij HA, van der Sluijs JA, Vermeulen RJ, Goslings JC, Luitse JS, Poll-Thé BT, Beelen A, van der Wees M, Kemps RJ, Catsman-Berrevoets CE, Oosterlaan J.

Pediatrics. 2015 Sep;136(3):534-41. doi: 10.1542/peds.2015-0437. Epub 2015 Aug 3.

35.

Can we predict efficacy of the ketogenic diet in children with refractory epilepsy?

Vehmeijer FO, van der Louw EJ, Arts WF, Catsman-Berrevoets CE, Neuteboom RF.

Eur J Paediatr Neurol. 2015 Nov;19(6):701-5. doi: 10.1016/j.ejpn.2015.06.004. Epub 2015 Jul 9.

PMID:
26206425
36.

Altered PLP1 splicing causes hypomyelination of early myelinating structures.

Kevelam SH, Taube JR, van Spaendonk RM, Bertini E, Sperle K, Tarnopolsky M, Tonduti D, Valente EM, Travaglini L, Sistermans EA, Bernard G, Catsman-Berrevoets CE, van Karnebeek CD, Østergaard JR, Friederich RL, Fawzi Elsaid M, Schieving JH, Tarailo-Graovac M, Orcesi S, Steenweg ME, van Berkel CG, Waisfisz Q, Abbink TE, van der Knaap MS, Hobson GM, Wolf NI.

Ann Clin Transl Neurol. 2015 Jun;2(6):648-61. doi: 10.1002/acn3.203. Epub 2015 May 1.

37.

Effectiveness of a hybrid corticosteroid treatment regimen on refractory childhood seizures and a review of other corticosteroid treatments.

Bakker DP, Catsman-Berrevoets CE, Neuteboom RF.

Eur J Paediatr Neurol. 2015 Sep;19(5):553-60. doi: 10.1016/j.ejpn.2015.04.006. Epub 2015 Apr 29.

PMID:
25976064
38.

Posterior fossa syndrome in a patient with an ornithine transcarbamylase deficiency.

Nedermeijer SC, van den Hout J, Geleijns C, de Klerk H, Catsman-Berrevoets CE.

Eur J Paediatr Neurol. 2015 May;19(3):364-6. doi: 10.1016/j.ejpn.2014.12.001. Epub 2014 Dec 24.

PMID:
25687292
39.

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.

Ketelslegers IA, Van Pelt DE, Bryde S, Neuteboom RF, Catsman-Berrevoets CE, Hamann D, Hintzen RQ.

Mult Scler. 2015 Oct;21(12):1513-20. doi: 10.1177/1352458514566666. Epub 2015 Feb 6.

PMID:
25662345
40.

Long-term outcome of Guillain-Barré syndrome in children.

Roodbol J, de Wit MC, Aarsen FK, Catsman-Berrevoets CE, Jacobs BC.

J Peripher Nerv Syst. 2014 Jun;19(2):121-6. doi: 10.1111/jns5.12068.

PMID:
24863162
41.

Blinded by shiga toxin-producing O104 Escherichia coli and hemolytic uremic syndrome.

Loudon SE, Dorresteijn EM, Catsman-Berrevoets CE, Verdijk RM, Simonsz HJ, Jansen AJ.

J Pediatr. 2014 Aug;165(2):410-410.e1. doi: 10.1016/j.jpeds.2014.04.008. Epub 2014 May 17. No abstract available.

PMID:
24840758
42.

Long-term outcome in children with low grade tectal tumours and obstructive hydrocephalus.

Aarsen FK, Arts WF, Van Veelen-Vincent ML, Lequin MH, Catsman-Berrevoets CE.

Eur J Paediatr Neurol. 2014 Jul;18(4):469-74. doi: 10.1016/j.ejpn.2014.03.002. Epub 2014 Mar 12.

PMID:
24657012
43.

Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.

van Pelt ED, Neuteboom RF, Ketelslegers IA, Boon M, Catsman-Berrevoets CE, Hintzen RQ; Dutch Study Group for Paediatric MS.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):790-4. doi: 10.1136/jnnp-2013-306850. Epub 2013 Dec 5.

PMID:
24309267
44.

Psychometric evaluation of the Dutch language version of the Child and Family Follow-up Survey.

de Kloet AJ, Berger MA, Bedell GM, Catsman-Berrevoets CE, van Markus-Doornbosch F, Vliet Vlieland TP.

Dev Neurorehabil. 2015;18(6):357-64. doi: 10.3109/17518423.2013.850749. Epub 2013 Dec 4.

PMID:
24304040
45.

Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.

van Pelt ED, Mescheriakova JY, Makhani N, Ketelslegers IA, Neuteboom RF, Kundu S, Broer L, Janssens C, Catsman-Berrevoets CE, van Duijn CM, Banwell B, Bar-Or A, Hintzen RQ.

Neurology. 2013 Dec 3;81(23):1996-2001. doi: 10.1212/01.wnl.0000436934.40034eb. Epub 2013 Nov 6.

PMID:
24198294
46.

Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.

van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A, de Wit MC, Descheemaeker MJ, Vergouwe Y, Catsman-Berrevoets CE, Legius E, Elgersma Y, Moll HA.

Lancet Neurol. 2013 Nov;12(11):1076-83. doi: 10.1016/S1474-4422(13)70227-8. Epub 2013 Oct 1.

PMID:
24090588
47.

Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination.

Verhey LH, van Pelt-Gravesteijn ED, Ketelslegers IA, Neuteboom RF, Catsman-Berrevoets CE, Feldman BM, Streiner DL, Sled JG, Hintzen RQ, Banwell B.

Mult Scler Relat Disord. 2013 Jul;2(3):193-9. doi: 10.1016/j.msard.2012.12.003. Epub 2013 Feb 1.

PMID:
25877725
48.

Youth with acquired brain injury in The Netherlands: a multi-centre study.

de Kloet AJ, Hilberink SR, Roebroeck ME, Catsman-Berrevoets CE, Peeters E, Lambregts SA, van Markus-Doornbosch F, Vliet Vlieland TP.

Brain Inj. 2013;27(7-8):843-9. doi: 10.3109/02699052.2013.775496. Epub 2013 Jun 12.

PMID:
23758314
49.

Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study.

Ketelslegers IA, Catsman-Berrevoets CE, Neuteboom RF, Boon M, van Dijk KG, Eikelenboom MJ, Gooskens RH, Niks EH, Overweg-Plandsoen WC, Peeters EA, Peeters-Scholte CM, Poll-The BT, de Rijk-van Andel JF, Samijn JP, Snoeck IN, Stroink H, Vermeulen RJ, Verrips A, Vles JS, Willemsen MA, Rodrigues Pereira R, Hintzen RQ.

J Neurol. 2012 Sep;259(9):1929-35. doi: 10.1007/s00415-012-6441-6. Epub 2012 Feb 17.

50.

Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.

Verhagen MM, Last JI, Hogervorst FB, Smeets DF, Roeleveld N, Verheijen F, Catsman-Berrevoets CE, Wulffraat NM, Cobben JM, Hiel J, Brunt ER, Peeters EA, Gómez Garcia EB, van der Knaap MS, Lincke CR, Laan LA, Tijssen MA, van Rijn MA, Majoor-Krakauer D, Visser M, van 't Veer LJ, Kleijer WJ, van de Warrenburg BP, Warris A, de Groot IJ, de Groot R, Broeks A, Preijers F, Kremer BH, Weemaes CM, Taylor MA, van Deuren M, Willemsen MA.

Hum Mutat. 2012 Mar;33(3):561-71. doi: 10.1002/humu.22016. Epub 2012 Jan 25.

PMID:
22213089

Supplemental Content

Loading ...
Support Center